Bank Of America Corp Cytokinetics Inc Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of America Corp holds 2,702,874 shares of CYTK stock, worth $83.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,702,874

Previous 219,121 1133.51%

Holding current value

$83.1 Million

Previous $10.3 Million 953.92%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$40.19 - $51.12 $99.8 Million - $127 Million	2,483,753 Added 1133.51%	2,702,874 $109 Million
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $214 Million - $270 Million	-4,610,302 Reduced 95.46%	219,121 $10.3 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $23 Million - $27 Million	448,654 Added 10.24%	4,829,423 $255 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $19 Million - $29.8 Million	-396,859 Reduced 8.31%	4,380,769 $237 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $288 Million - $487 Million	4,510,857 Added 1690.91%	4,777,628 $335 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $155,688 - $483,574	5,792 Added 2.22%	266,771 $22.3 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $30.7 Million - $38.4 Million	-942,276 Reduced 78.31%	260,979 $8.51 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $28.5 Million - $39 Million	854,101 Added 244.62%	1,203,255 $42.3 Million
Q4 2022 Feb 10, 2023	BUY	$35.77 - $51.11 $3.05 Million - $4.36 Million	85,215 Added 32.29%	349,154 $16 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.25 Million - $1.77 Million	32,463 Added 14.02%	263,939 $12.8 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $6.37 Million - $9.18 Million	-187,681 Reduced 44.78%	231,476 $9.09 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $3.7 Million - $5.72 Million	124,424 Added 42.22%	419,157 $15.4 Million
Q4 2021 Feb 08, 2022	BUY	$34.35 - $46.38 $2.17 Million - $2.93 Million	63,094 Added 27.24%	294,733 $13.4 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $255,166 - $491,889	-13,763 Reduced 5.61%	231,639 $8.28 Million
Q2 2021 Sep 13, 2021	BUY	$19.79 - $26.99 $4.86 Million - $6.62 Million	245,402 New	245,402 $4.86 Million

Others Institutions Holding CYTK

# of Institutions

408

Shares Held

127M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $2.89B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cytokinetics Inc Transaction History